EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CriSNPr, a single interface for the curated and de novo design of gRNAs for CRISPR diagnostics using diverse Cas systems

Asgar H Ansari iD, Manoj Kumar iD, Sajal Sarkar, Souvik Maiti, Debojyoti Chakraborty iD

eLife · 2023

DOI: 10.7554/elife.77976 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Asgar H Ansari und 4 weiteren Autor:innen. Beteiligte Einrichtung: CSIR-Institute of Genomics & Integrative Biology, New Delhi, India. Hauptthemen laut MEDLINE: COVID-19, CRISPR-Cas Systems, RNA, Guide, CRISPR-Cas Systems. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EMBO, Lady Tata Memorial Trust, CSIR-Sickle Cell Mission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR-based diagnostics (CRISPRDx) have improved clinical decision-making, especially during the COVID-19 pandemic, by detecting nucleic acids and identifying variants. This has been accelerated by the discovery of new and engineered CRISPR effectors, which have expanded the portfolio of diagnostic applications to include a broad range of pathogenic and non-pathogenic conditions. However, each diagnostic CRISPR pipeline necessitates customized detection schemes based on the fundamental principles of the Cas protein used, its guide RNA (gRNA) design parameters, and the assay readout. This is especially relevant for variant detection, a low-cost alternative to sequencing-based approaches for which no in silico pipeline for the ready-to-use design of CRISPRDx currently exists. In this manuscript, we fill this lacuna using a unified web server, CriSNPr (CRISPR-based SNP recognition), which provides the user with the opportunity to de novo design gRNAs based on six CRISPRDx proteins of choice ( Fn /en Fn Cas9, Lw Cas13a, Lb Cas12a, Aa Cas12b, and Cas14a) and query for ready-to-use oligonucleotide sequences for validation on relevant samples. Furthermore, we provide a database of curated pre-designed gRNAs as well as target/off-target for all human and SARS-CoV-2 variants reported thus far. CriSNPr has been validated on multiple Cas proteins, demonstrating its broad and immediate applicability across multiple detection platforms. CriSNPr can be found at http://crisnpr.igib.res.in/ .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsHumansCOVID-19 TestingPandemicsSARS-CoV-2

Stichwörter der Autor:innen

CRISPR-diagnosticsSNVcomputational biologyepidemiologyglobal healthhumansars-cov-2sgRNAsystems biologyvariant-detection

Substanzen

RNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • CSIR-Institute of Genomics & Integrative Biology, New Delhi, India.
  • Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India.

ORCID-Profile: Asgar H Ansari, Manoj Kumar, Debojyoti Chakraborty

Förderung

  • EMBO
  • Lady Tata Memorial Trust
  • CSIR-Sickle Cell Mission

Zitieren

APA

Ansari, A. H., Kumar, M., Sarkar, S., Maiti, S., & Chakraborty, D. (2023). CriSNPr, a single interface for the curated and de novo design of gRNAs for CRISPR diagnostics using diverse Cas systems. eLife. https://doi.org/10.7554/elife.77976

Vancouver

Ansari AH, Kumar M, Sarkar S, Maiti S, Chakraborty D. CriSNPr, a single interface for the curated and de novo design of gRNAs for CRISPR diagnostics using diverse Cas systems. eLife. 2023. doi:10.7554/elife.77976

BibTeX
@article{Ansari2023,
  author = {Ansari, Asgar H and Kumar, Manoj and Sarkar, Sajal and Maiti, Souvik and Chakraborty, Debojyoti},
  title = {CriSNPr, a single interface for the curated and de novo design of gRNAs for CRISPR diagnostics using diverse Cas systems},
  journal = {eLife},
  year = {2023},
  doi = {10.7554/elife.77976}
}
Kostenlos starten →